Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Inventory (2019 - 2025)

Pulmonx has reported Inventory over the past 7 years, most recently at $15.8 million for Q4 2025.

  • Quarterly Inventory fell 6.33% to $15.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.8 million through Dec 2025, down 6.33% year-over-year, with the annual reading at $15.8 million for FY2025, 6.33% down from the prior year.
  • Inventory was $15.8 million for Q4 2025 at Pulmonx, down from $16.2 million in the prior quarter.
  • Over five years, Inventory peaked at $19.2 million in Q2 2022 and troughed at $11.9 million in Q1 2021.
  • The 5-year median for Inventory is $16.2 million (2025), against an average of $16.1 million.
  • Year-over-year, Inventory skyrocketed 61.34% in 2021 and then dropped 18.61% in 2023.
  • A 5-year view of Inventory shows it stood at $16.3 million in 2021, then fell by 10.57% to $14.6 million in 2022, then rose by 14.96% to $16.7 million in 2023, then increased by 1.03% to $16.9 million in 2024, then decreased by 6.33% to $15.8 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Inventory are $15.8 million (Q4 2025), $16.2 million (Q3 2025), and $16.2 million (Q2 2025).